You are here
Singapore-based private equity firm in Indonesia pharma deal
SINGAPORE-BASED private equity firm Quadria Capital has sealed a "multi-million dollar" deal with its investment in Indonesia's PT Soho Global Health (SGH), in a partnership with German development finance institution DEG.
"The funds will be used to create access to innovative, differentiated drugs through in-licensing from developed markets, acquire strategic assets and support the growth of the medical device sector," Quadria Capital said in a statement on Thursday.
Quadria Capital, which focuses on the healthcare sector, also said that this transaction is the first private equity deal in Indonesia's pharmaceutical industry.
SGH produces, markets and distributes natural medicines, prescription and over-the-counter products across Indonesia. Its distribution network covers more than 80 per cent of hospitals and 90 per cent of pharmacies in Indonesia.